Healthcare -
Biotechnology - NASDAQ - US
$ 18.37
-0.541 %
$ 1.6 B
Market Cap
-4.06
P/E
TVTX - CAPITAL EXPENDITURES
Capital Expenditures TVTX - Travere Therapeutics, Inc.
-668 K
LAST VALUE
83.37%
2 YEAR CAGR
49.18%
5 YEAR CAGR
19.08%
10 YEAR CAGR